NCT01419236

A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 76 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Male
• Age: 26 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to see if testosterone solution 2% can impact symptoms of ejaculatory dysfunction in men with low testosterone.

Conditions

• Ejaculatory Dysfunction
• Hypogonadism

Interventions

Type	Name	Description
DRUG	Testosterone Solution 2%	Administered topically
DRUG	Placebo Solution	Administered topically

Timeline

• Start date: 2011-08-01
• Primary completion: 2013-12-01
• Completion: 2013-12-01
• First posted: 2011-08-18
• Last updated: 2014-12-19
• Results posted: 2014-12-19

Locations

7 sites across 2 countries: United States, Canada